DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS.

Efforts to develop anti-cancer therapies have largely focused on targeting the epithelial compartment, despite the presence of non-neoplastic stromal components that substantially contribute to the progression of the tumor. Indeed, cancer cell survival, growth, migration and even dormancy are influenced by the surrounding tumor microenvironment (TME). Within the TME, cancer-associated fibroblasts (CAFs) have been shown to play several roles in the development of a tumor. They secrete growth factors, inflammatory ligands and extracellular matrix proteins that promote cancer cell proliferation, therapy resistance and immune exclusion. However, recent work indicates that CAFs may also restrain tumor progression in some circumstances. In this review, we summarize the body of work on CAFs, with a particular focus on the most recent discoveries about fibroblast heterogeneity, plasticity and functions. We also highlight the commonalities of fibroblasts present across different cancer types, and in normal and inflammatory states. Finally, we present the latest advances regarding therapeutic strategies targeting CAFs that are undergoing pre-clinical and clinical evaluation.

[1]  Jing Cai,et al.  The metastatic phenotype shift towards myofibroblast of adipose-derived mesenchymal stem cells promotes ovarian cancer progression. , 2020, Carcinogenesis.

[2]  M. Gorospe,et al.  Survey of senescent cell markers with age in human tissues , 2020, Aging.

[3]  Huamin Wang,et al.  Transgenic Expression of PRSS1R122H Sensitizes Mice to Pancreatitis. , 2020, Gastroenterology.

[4]  P. Robbins,et al.  Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice , 2020, Aging cell.

[5]  Thea D. Tlsty,et al.  A framework for advancing our understanding of cancer-associated fibroblasts , 2020, Nature Reviews Cancer.

[6]  H. Moch,et al.  The single-cell pathology landscape of breast cancer , 2020, Nature.

[7]  K. Kataoka,et al.  TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity , 2020, Theranostics.

[8]  Michelle A. Anderson,et al.  Regulatory T cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis. , 2020, Cancer discovery.

[9]  K. Pollard,et al.  Abstract PR12: The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice , 2019, Model Systems.

[10]  A. Weeraratna,et al.  How the ageing microenvironment influences tumour progression , 2019, Nature Reviews Cancer.

[11]  Ying Wang,et al.  Trypsin activity governs increased susceptibility to pancreatitis in mice expressing human PRSS1R122H. , 2019, The Journal of clinical investigation.

[12]  R. Bourgon,et al.  Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy. , 2019, Cancer discovery.

[13]  D. Tuveson,et al.  Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation , 2019, bioRxiv.

[14]  K. Pradhan,et al.  Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts , 2019, eLife.

[15]  R. Brekken,et al.  Targeting TGFβR2‐mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer , 2019, EMBO molecular medicine.

[16]  B. Vanderhyden,et al.  Metformin Abrogates Age-Associated Ovarian Fibrosis , 2019, Clinical Cancer Research.

[17]  M. Snyder,et al.  Heterogeneity in old fibroblasts is linked to variability in reprogramming and wound healing , 2019, Nature.

[18]  Jonathan M. Hernandez,et al.  Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer. , 2019, Cancer cell.

[19]  Dalei Wu,et al.  LECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis , 2019, Cell.

[20]  S. Carr,et al.  Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells , 2019, Proceedings of the National Academy of Sciences.

[21]  David R. Croucher,et al.  CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan , 2019, Nature Communications.

[22]  P. Robson,et al.  Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. , 2019, Cancer discovery.

[23]  Charles A. Harris,et al.  A Stromal Niche Defined by Expression of the Transcription Factor WT1 Mediates Programming and Homeostasis of Cavity-Resident Macrophages. , 2019, Immunity.

[24]  Pan‐Chyr Yang,et al.  Cancer-associated fibroblasts produce Netrin-1 to control cancer cell plasticity. , 2019, Cancer research.

[25]  Yun-Gui Yang,et al.  Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma , 2019, Cell Research.

[26]  Jonathan J. West,et al.  An optimised tissue disaggregation and data processing pipeline for characterising fibroblast phenotypes using single-cell RNA sequencing , 2019, Scientific Reports.

[27]  Jeffrey W. Clark,et al.  Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial. , 2019, JAMA oncology.

[28]  S. Stewart,et al.  Unmasking senescence: context-dependent effects of SASP in cancer , 2019, Nature Reviews Cancer.

[29]  K. Toh,et al.  Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment. , 2019, ACS nano.

[30]  M. Grinstaff,et al.  Intraarticular injection of relaxin-2 alleviates shoulder arthrofibrosis , 2019, Proceedings of the National Academy of Sciences.

[31]  S. Raychaudhuri,et al.  Distinct fibroblast subsets drive inflammation and damage in arthritis , 2019, Nature.

[32]  R. Hynes,et al.  Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix , 2019, Proceedings of the National Academy of Sciences.

[33]  M. Mann,et al.  Proteomics reveals NNMT as a master metabolic regulator of cancer associated fibroblasts , 2019, Nature.

[34]  A. Kanai,et al.  Relaxin and fibrosis: Emerging targets, challenges, and future directions , 2019, Molecular and Cellular Endocrinology.

[35]  R. Jain,et al.  Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy , 2019, Proceedings of the National Academy of Sciences.

[36]  C. Shao,et al.  Inflammatory and Senescent Phenotype of Pancreatic Stellate Cells Induced by Sqstm1 Downregulation Facilitates Pancreatic Cancer Progression , 2019, International journal of biological sciences.

[37]  Zhao-Jun Liu,et al.  Intracellular Notch1 Signaling in Cancer‐Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells , 2019, Stem cells.

[38]  A. Alimonti,et al.  Cellular Senescence: Aging, Cancer, and Injury. , 2019, Physiological reviews.

[39]  Galina A. Erikson,et al.  Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring , 2019, Nature.

[40]  R. Sears,et al.  A Stromal Lysolipid-Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression. , 2019, Cancer discovery.

[41]  P. Philip,et al.  Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  J. Kleeff,et al.  Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma , 2019, The Journal of pathology.

[43]  M. Borad,et al.  Hepatocytes direct the formation of a pro-metastatic niche in the liver. , 2019, Nature.

[44]  R. Jain,et al.  Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges. , 2019, Annual review of physiology.

[45]  Qing Nie,et al.  Single-cell analysis reveals fibroblast heterogeneity and myeloid-derived adipocyte progenitors in murine skin wounds , 2019, Nature Communications.

[46]  A. Maitra,et al.  Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution , 2019, bioRxiv.

[47]  R. Jain,et al.  Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer , 2019, Proceedings of the National Academy of Sciences.

[48]  A. Califano,et al.  Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes , 2019, Gut.

[49]  D. Ingber,et al.  Modelling cancer in microfluidic human organs-on-chips , 2019, Nature Reviews Cancer.

[50]  Ellen M. Langer,et al.  Modeling Tumor Phenotypes In Vitro with Three-Dimensional Bioprinting , 2019, Cell reports.

[51]  S. Thorpe,et al.  Tamoxifen mechanically reprograms the tumor microenvironment via HIF‐1A and reduces cancer cell survival , 2018, EMBO reports.

[52]  S. Thorpe,et al.  GPER is a mechanoregulator of pancreatic stellate cells and the tumor microenvironment , 2018, EMBO reports.

[53]  Åsa K. Björklund,et al.  Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing , 2018, Nature Communications.

[54]  Chiara Sabatti,et al.  Organoid Modeling of the Tumor Immune Microenvironment , 2018, Cell.

[55]  Damon A. Clark,et al.  Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair , 2018, Science.

[56]  A. Biankin,et al.  ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling , 2018, Nature Communications.

[57]  Paolo P. Provenzano,et al.  Antifibrotic Therapy Disrupts Stromal Barriers and Modulates the Immune Landscape in Pancreatic Ductal Adenocarcinoma. , 2018, Cancer research.

[58]  Camille Stephan-Otto Attolini,et al.  Identity Noise and Adipogenic Traits Characterize Dermal Fibroblast Aging , 2018, Cell.

[59]  V. Greco,et al.  Positional Stability and Membrane Occupancy Define Skin Fibroblast Homeostasis In Vivo , 2018, Cell.

[60]  J. Norman,et al.  Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels , 2018, Nature Communications.

[61]  M. Sahin-Tóth,et al.  A preclinical model of chronic pancreatitis driven by trypsinogen autoactivation , 2018, Nature Communications.

[62]  D. Tuveson,et al.  IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma. , 2018, Cancer discovery.

[63]  E. Song,et al.  Turning foes to friends: targeting cancer-associated fibroblasts , 2018, Nature Reviews Drug Discovery.

[64]  Ming Yan,et al.  RETRACTED ARTICLE: Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7 , 2018, Cell Death & Disease.

[65]  Principal Investigators,et al.  Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris , 2018 .

[66]  Stephen M. Douglass,et al.  Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility. , 2018, Cancer discovery.

[67]  Quin F. Wills,et al.  Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease , 2018, Cell.

[68]  James T. Webber,et al.  Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris , 2018, Nature.

[69]  Meena Subramaniam,et al.  Lineage dynamics of murine pancreatic development at single-cell resolution , 2018, Nature Communications.

[70]  Maria C. Lecca,et al.  Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer , 2018, Nature Cell Biology.

[71]  Xiao Yang,et al.  Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem , 2018, Nature Communications.

[72]  D. Saur,et al.  Dual reporter genetic mouse models of pancreatic cancer identify an epithelial‐to‐mesenchymal transition‐independent metastasis program , 2018, EMBO molecular medicine.

[73]  F. Rojo,et al.  Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer , 2018, Nature Communications.

[74]  P. Carmeliet,et al.  Phenotype molding of stromal cells in the lung tumor microenvironment , 2018, Nature Medicine.

[75]  S. Lowe,et al.  Tumor Cell‐Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy , 2018, Immunity.

[76]  L. Ding,et al.  Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19 , 2018, Theranostics.

[77]  M. Pajic,et al.  Rho Kinase Inhibition by AT13148 Blocks Pancreatic Ductal Adenocarcinoma Invasion and Tumor Growth. , 2018, Cancer research.

[78]  I. Ulitsky,et al.  Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features , 2018, Proceedings of the National Academy of Sciences.

[79]  Timothy J. Peters,et al.  Enduring epigenetic landmarks define the cancer microenvironment , 2018, Genome research.

[80]  P. Scheet,et al.  Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression , 2018, Clinical Cancer Research.

[81]  J. Grillari,et al.  Cellular Senescence and Inflammaging in Age-Related Diseases , 2018, Mediators of inflammation.

[82]  R. Weinberg,et al.  The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy , 2018, Science Translational Medicine.

[83]  F. Watt,et al.  Spatial and Single-Cell Transcriptional Profiling Identifies Functionally Distinct Human Dermal Fibroblast Subpopulations , 2018, The Journal of investigative dermatology.

[84]  Kelsey N. Retting,et al.  Bioprinted 3D Primary Human Intestinal Tissues Model Aspects of Native Physiology and ADME/Tox Functions , 2018, iScience.

[85]  Peter Chen,et al.  Single-Cell Deconvolution of Fibroblast Heterogeneity in Mouse Pulmonary Fibrosis , 2018, Cell reports.

[86]  D. Ma,et al.  Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer , 2018, Molecular Cancer Therapeutics.

[87]  Inna Kuperstein,et al.  Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer. , 2018, Cancer cell.

[88]  J. Locasale,et al.  Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells , 2018, Nature Cell Biology.

[89]  C. Martins,et al.  Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells , 2018, Nature Communications.

[90]  Nir Hacohen,et al.  Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis , 2018, Nature Communications.

[91]  Camille Stephan-Otto Attolini,et al.  TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis , 2018, Nature.

[92]  H. Yao,et al.  CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness , 2018, Cell.

[93]  L. Zender,et al.  Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics , 2018, Nature Reviews Gastroenterology & Hepatology.

[94]  A. Trumpp,et al.  Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors , 2018, Proceedings of the National Academy of Sciences.

[95]  R. Bourgon,et al.  TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells , 2018, Nature.

[96]  F. Nicoletti,et al.  Ageing: from inflammation to cancer , 2018, Immunity & Ageing.

[97]  Hongyang Wang,et al.  Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer , 2018, Nature Communications.

[98]  Seok Chung,et al.  Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance , 2018, Journal of Experimental & Clinical Cancer Research.

[99]  F. Watt,et al.  Fibroblast heterogeneity: implications for human disease , 2018, The Journal of clinical investigation.

[100]  M. Kolonin,et al.  PDGFRα/PDGFRβ signaling balance modulates progenitor cell differentiation into white and beige adipocytes , 2018, Development.

[101]  F. Watt,et al.  Fibroblast state switching orchestrates dermal maturation and wound healing , 2017, bioRxiv.

[102]  J. Gimble,et al.  Obesity Enhances the Conversion of Adipose-Derived Stromal/Stem Cells into Carcinoma-Associated Fibroblast Leading to Cancer Cell Proliferation and Progression to an Invasive Phenotype , 2017, Stem cells international.

[103]  Lei Zheng,et al.  HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[104]  Peng Hu,et al.  Dissecting Cell-Type Composition and Activity-Dependent Transcriptional State in Mammalian Brains by Massively Parallel Single-Nucleus RNA-Seq. , 2017, Molecular cell.

[105]  E. Puré,et al.  Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[106]  Chunsheng Zhang,et al.  Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors. , 2017, Cancer cell.

[107]  Alissa M. Weaver,et al.  Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin , 2017, The Journal of cell biology.

[108]  V. Weaver,et al.  Tissue Force Programs Cell Fate and Tumor Aggression. , 2017, Cancer discovery.

[109]  Shawn M. Gillespie,et al.  Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer , 2017, Cell.

[110]  S. Quake,et al.  Single-Cell Analysis of Human Pancreas Reveals Transcriptional Signatures of Aging and Somatic Mutation Patterns , 2017, Cell.

[111]  E. Puré,et al.  Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma. , 2017, JCI insight.

[112]  W. Cho,et al.  Cancer and Aging - the Inflammatory Connection , 2017, Aging and disease.

[113]  A. van Oudenaarden,et al.  Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations , 2017, Nature Methods.

[114]  Joshua D. Welch,et al.  Single Cell Transcriptomics Reconstructs Fate Conversion from Fibroblast to Cardiomyocyte , 2017, Nature.

[115]  Harini Veeraraghavan,et al.  Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient , 2017, Cell.

[116]  Aviv Regev,et al.  Massively-parallel single nucleus RNA-seq with DroNc-seq , 2017, Nature Methods.

[117]  V. Weaver,et al.  Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells , 2017, Cancer Immunology Research.

[118]  M. V. Vander Heiden,et al.  Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions , 2017, Nature Communications.

[119]  P. Papageorgis,et al.  Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner , 2017, Scientific Reports.

[120]  Max Nobis,et al.  Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis , 2017, Science Translational Medicine.

[121]  L. J. K. Wee,et al.  Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors , 2017, Nature Genetics.

[122]  Hans Clevers,et al.  Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer , 2017, The Journal of experimental medicine.

[123]  Takuya Kato,et al.  A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion , 2017, Nature Cell Biology.

[124]  P. Papageorgis,et al.  Pirfenidone normalizes the tumor microenvironment to improve chemotherapy , 2017, Oncotarget.

[125]  E. Collisson,et al.  Stromal cues regulate the pancreatic cancer epigenome and metabolome , 2017, Proceedings of the National Academy of Sciences.

[126]  T. Gress,et al.  Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer , 2017, Gut.

[127]  Gabriela Kalna,et al.  ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth , 2016, EMBO molecular medicine.

[128]  D. Tuveson,et al.  Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors. , 2016, Cancer research.

[129]  D. Fearon,et al.  Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity , 2016, Cell metabolism.

[130]  Michael C. Ostrowski,et al.  IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer , 2016, Gut.

[131]  F. Notta,et al.  Senescent Carcinoma-Associated Fibroblasts Upregulate IL8 to Enhance Prometastatic Phenotypes , 2016, Molecular Cancer Research.

[132]  Toby C. Cornish,et al.  Metastatic progression is associated with dynamic changes in the local microenvironment , 2016, Nature Communications.

[133]  E. Jaffee,et al.  Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation. , 2016, Cancer research.

[134]  J. Hartman,et al.  Pericyte–fibroblast transition promotes tumor growth and metastasis , 2016, Proceedings of the National Academy of Sciences.

[135]  R. Kalluri The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[136]  L. Cantley,et al.  Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion , 2016, Nature.

[137]  T. Welling,et al.  GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic Cancer. , 2016, Cancer discovery.

[138]  Masashi Narita,et al.  NOTCH1 mediates a switch between two distinct secretomes during senescence , 2016, Nature Cell Biology.

[139]  Yuli Lin,et al.  FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling. , 2016, Cancer research.

[140]  W. Zhang,et al.  Impaired DNA double-strand break repair contributes to the age-associated rise of genomic instability in humans , 2016, Cell Death and Differentiation.

[141]  S. Rose-John,et al.  Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival. , 2016, Gastroenterology.

[142]  R. Weichselbaum,et al.  Tumor-associated fibroblasts predominantly come from local and not circulating precursors , 2016, Proceedings of the National Academy of Sciences.

[143]  Jingqin Luo,et al.  Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis , 2016, Nature Communications.

[144]  D. Weaver,et al.  Targeting Focal Adhesion Kinase Renders Pancreatic Cancers Responsive to Checkpoint Immunotherapy , 2016, Nature Medicine.

[145]  I. Ng,et al.  Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling. , 2016, Cell reports.

[146]  Pallav Sengupta,et al.  Men and mice: Relating their ages. , 2016, Life sciences.

[147]  D. Tuveson,et al.  Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis , 2016, Nature Cell Biology.

[148]  Christine A Iacobuzio-Donahue,et al.  Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular-fibrosis and tumor progression , 2016, Nature Medicine.

[149]  Charles H. Yoon,et al.  Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq , 2016, Science.

[150]  R. Buckanovich,et al.  Mesenchymal Stem Cells Promote Pancreatic Tumor Growth by Inducing Alternative Polarization of Macrophages12 , 2016, Neoplasia.

[151]  M. Vannier,et al.  A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma , 2016, Pancreas.

[152]  Prahlad T. Ram,et al.  Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism , 2016, eLife.

[153]  R. Gibbs,et al.  Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.

[154]  L. Ferrucci,et al.  sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance , 2016, Nature.

[155]  R. Holcombe,et al.  Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer , 2016, Clinical Cancer Research.

[156]  V. Sanz-Moreno,et al.  Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts , 2015, Nature Communications.

[157]  F. Greten,et al.  IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis , 2015, The Journal of experimental medicine.

[158]  R. Jain,et al.  Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages , 2015, PloS one.

[159]  G. Kollias,et al.  IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer , 2015, The Journal of experimental medicine.

[160]  Yuchang Li,et al.  Myofibroblastic Conversion and Regeneration of Mesothelial Cells in Peritoneal and Liver Fibrosis. , 2015, The American journal of pathology.

[161]  R. Datar,et al.  Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer. , 2015, Cancer research.

[162]  R. Salgia,et al.  Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[163]  D. Melisi,et al.  IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation , 2015, Clinical Cancer Research.

[164]  A. Saluja,et al.  Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer , 2015, Clinical Cancer Research.

[165]  Jen Jen Yeh,et al.  Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma , 2015, Nature Genetics.

[166]  G. Charras,et al.  Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis , 2015, EMBO reports.

[167]  N. Grabe,et al.  Characterization of Skin Aging-Associated Secreted Proteins (SAASP) Produced by Dermal Fibroblasts Isolated from Intrinsically Aged Human Skin. , 2015, The Journal of investigative dermatology.

[168]  Guillaume Lamour,et al.  Changes in Structural-Mechanical Properties and Degradability of Collagen during Aging-associated Modifications* , 2015, The Journal of Biological Chemistry.

[169]  Jeffrey A Jones,et al.  Hematopoietic Stem Cell–Derived Cancer–Associated Fibroblasts Are Novel Contributors to the Pro-Tumorigenic Microenvironment , 2015, Neoplasia.

[170]  Aaron M. Newman,et al.  Identification and isolation of a dermal lineage with intrinsic fibrogenic potential , 2015, Science.

[171]  J. Trebicka,et al.  The carbon tetrachloride model in mice , 2015, Laboratory animals.

[172]  J. Mi,et al.  Metabolic reprogramming of cancer-associated fibroblasts by IDH3α downregulation. , 2015, Cell reports.

[173]  Caroline H. Diep,et al.  Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer , 2015, Clinical Cancer Research.

[174]  S. Hayward,et al.  Stretching Fibroblasts Remodels Fibronectin and Alters Cancer Cell Migration , 2015, Scientific Reports.

[175]  Paul Martin,et al.  Wound repair and regeneration: Mechanisms, signaling, and translation , 2014, Science Translational Medicine.

[176]  V. Weaver,et al.  The extracellular matrix modulates the hallmarks of cancer , 2014, EMBO reports.

[177]  Z. Werb,et al.  Remodelling the extracellular matrix in development and disease , 2014, Nature Reviews Molecular Cell Biology.

[178]  Andrii Savchenko,et al.  Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent , 2014, Proceedings of the National Academy of Sciences.

[179]  Benjamin L. Allen,et al.  Dosage-dependent regulation of pancreatic cancer growth and angiogenesis by hedgehog signaling. , 2014, Cell reports.

[180]  D. Sahoo,et al.  Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors. , 2014, Cancer cell.

[181]  Fabian J Theis,et al.  Proteome-wide analysis reveals an age-associated cellular phenotype of in situ aged human fibroblasts , 2014, Aging.

[182]  Edward J. Kim,et al.  Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma , 2014, Clinical Cancer Research.

[183]  G. Wahl,et al.  Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy , 2014, Cell.

[184]  J. Xie,et al.  Dexamethasone attenuates bleomycin-induced lung fibrosis in mice through TGF-β, Smad3 and JAK-STAT pathway. , 2014, International journal of clinical and experimental medicine.

[185]  E. Eichler,et al.  Evolutionary-new centromeres preferentially emerge within gene deserts , 2008, Genome Biology.

[186]  M. Fernández-Zapico,et al.  The Transcription Factor GLI1 Modulates the Inflammatory Response during Pancreatic Tissue Remodeling* , 2014, The Journal of Biological Chemistry.

[187]  Daniel Öhlund,et al.  Fibroblast heterogeneity in the cancer wound , 2014, The Journal of experimental medicine.

[188]  J. Willmann,et al.  Stromal response to Hedgehog signaling restrains pancreatic cancer progression , 2014, Proceedings of the National Academy of Sciences.

[189]  Umar Mahmood,et al.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. , 2014, Cancer cell.

[190]  Stephen A. Sastra,et al.  Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. , 2014, Cancer cell.

[191]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[192]  Å. Borg,et al.  Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties. , 2014, Cancer research.

[193]  R. Sussman,et al.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.

[194]  H. Collard,et al.  Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.

[195]  E. Giannoni,et al.  Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression , 2014, Oncogene.

[196]  Marc L. Mendillo,et al.  The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy , 2014, Cell.

[197]  T. Giese,et al.  Prevailing Role of Contact Guidance in Intrastromal T-cell Trapping in Human Pancreatic Cancer , 2014, Clinical Cancer Research.

[198]  Janna Paulsson,et al.  Prognostic relevance of cancer-associated fibroblasts in human cancer. , 2014, Seminars in cancer biology.

[199]  Ker-Chau Li,et al.  Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling , 2014, Nature Communications.

[200]  Cole Trapnell,et al.  The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells , 2014, Nature Biotechnology.

[201]  K. Stamatakis,et al.  Carcinoma‐associated fibroblasts derive from mesothelial cells via mesothelial‐to‐mesenchymal transition in peritoneal metastasis , 2013, The Journal of pathology.

[202]  Derek S. Chan,et al.  Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer , 2013, Proceedings of the National Academy of Sciences.

[203]  R. Schwabe,et al.  Fate-tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its etiology , 2013, Nature Communications.

[204]  Zainab Jagani,et al.  Unraveling the therapeutic potential of the Hedgehog pathway in cancer , 2013, Nature Medicine.

[205]  Fiona M. Watt,et al.  Distinct fibroblast lineages determine dermal architecture in skin development and repair , 2013, Nature.

[206]  J. Gribben,et al.  Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. , 2013, Gastroenterology.

[207]  B. Zetter,et al.  Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. , 2013, Cancer research.

[208]  W. Fibbe,et al.  Mesenchymal stromal cells: sensors and switchers of inflammation. , 2013, Cell stem cell.

[209]  Rakesh K. Jain,et al.  Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels , 2013, Nature Communications.

[210]  C. Dray,et al.  Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer. , 2013, Cancer research.

[211]  J. Foekens,et al.  Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma , 2013, Cell.

[212]  C. Pilarsky,et al.  CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer , 2013, Proceedings of the National Academy of Sciences.

[213]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[214]  James O. Jones,et al.  Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia , 2013, The Journal of experimental medicine.

[215]  Robert P. Jenkins,et al.  Mechano-transduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer associated fibroblasts , 2013, Nature Cell Biology.

[216]  D. Stainier,et al.  Hepatic stellate cells in liver development, regeneration, and cancer. , 2013, The Journal of clinical investigation.

[217]  R. Evans,et al.  A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response , 2013, Cell.

[218]  Kenneth J. Pienta,et al.  Recruitment of Mesenchymal Stem Cells Into Prostate Tumors Promotes Metastasis , 2013, Nature Communications.

[219]  K. Ohuchida,et al.  Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells. , 2013, Cancer research.

[220]  A. Zhavoronkov,et al.  The role of DNA damage and repair in aging through the prism of Koch-like criteria , 2013, Ageing Research Reviews.

[221]  Yuchang Li,et al.  Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial–mesenchymal transition in liver injury , 2013, Proceedings of the National Academy of Sciences.

[222]  E. Lengyel,et al.  MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. , 2012, Cancer discovery.

[223]  Olivier Gevaert,et al.  Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo. , 2012, Cancer research.

[224]  P. Jung,et al.  Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. , 2012, Cancer cell.

[225]  D. Sahoo,et al.  Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature , 2012, Nature Cell Biology.

[226]  E. Ziv,et al.  CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. , 2012, Cancer discovery.

[227]  G. Eberl,et al.  Lineage tracing and genetic ablation of ADAM12+ perivascular cells identify a major source of profibrotic cells during acute tissue injury , 2012, Nature Medicine.

[228]  A. Nagler,et al.  Involvement of Host Stroma Cells and Tissue Fibrosis in Pancreatic Tumor Development in Transgenic Mice , 2012, PloS one.

[229]  T. Golub,et al.  Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion , 2012, Nature.

[230]  Christopher K. Glass,et al.  Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis , 2012, Proceedings of the National Academy of Sciences.

[231]  S. Stewart,et al.  Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression. , 2012, Cancer research.

[232]  Carlos Cuevas,et al.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.

[233]  Yutao Yan,et al.  Dextran Sodium Sulfate (DSS) Induces Colitis in Mice by Forming Nano-Lipocomplexes with Medium-Chain-Length Fatty Acids in the Colon , 2012, PloS one.

[234]  Pierre Validire,et al.  Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. , 2012, The Journal of clinical investigation.

[235]  M. Andreeff,et al.  Origins of the Tumor Microenvironment: Quantitative Assessment of Adipose-Derived and Bone Marrow–Derived Stroma , 2012, PloS one.

[236]  T. Oskarsson,et al.  Extracellular matrix players in metastatic niches , 2012, The EMBO journal.

[237]  Hong Peng,et al.  Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.

[238]  Michael J. Cronce,et al.  Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition , 2011, Proceedings of the National Academy of Sciences.

[239]  Xiaowo Wang,et al.  Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. , 2011, Genes & development.

[240]  Hans Clevers,et al.  Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression. , 2011, Gastroenterology.

[241]  Raghu Kalluri,et al.  VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization , 2011, Proceedings of the National Academy of Sciences.

[242]  Ricardo Garcia,et al.  Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis , 2011, Cell.

[243]  F. Collins,et al.  Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts. , 2011, The Journal of clinical investigation.

[244]  Edi Brogi,et al.  Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs , 2011, Nature Medicine.

[245]  M. Barbacid,et al.  Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. , 2011, Cancer cell.

[246]  G. Kollias,et al.  Animal models for arthritis: innovative tools for prevention and treatment , 2011, Annals of the rheumatic diseases.

[247]  Stephen Gould,et al.  Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells , 2011, Proceedings of the National Academy of Sciences.

[248]  A. Masamune,et al.  Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signaling. , 2011, Cancer research.

[249]  Ju-Seog Lee,et al.  Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. , 2011, Cancer cell.

[250]  Richard A Flavell,et al.  Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation. , 2011, Immunity.

[251]  Hsiao-Chin Hong,et al.  Targeting Galectin-1 in Carcinoma-Associated Fibroblasts Inhibits Oral Squamous Cell Carcinoma Metastasis by Downregulating MCP-1/CCL2 Expression , 2011, Clinical Cancer Research.

[252]  Hiroyuki Tomita,et al.  Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. , 2011, Cancer cell.

[253]  Z. Werb,et al.  Dynamic, long-term in vivo imaging of tumor-stroma interactions in mouse models of breast cancer using spinning-disk confocal microscopy. , 2011, Cold Spring Harbor protocols.

[254]  R. Jain,et al.  Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors , 2011, Proceedings of the National Academy of Sciences.

[255]  Dai Fukumura,et al.  Malignant cells facilitate lung metastasis by bringing their own soil , 2010, Proceedings of the National Academy of Sciences.

[256]  James O. Jones,et al.  Suppression of Antitumor Immunity by Stromal Cells Expressing , 2022 .

[257]  Robert A. Weinberg,et al.  Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts , 2010, Proceedings of the National Academy of Sciences.

[258]  A. Nagler,et al.  Inhibition of Pancreatic Stellate Cell Activation by Halofuginone Prevents Pancreatic Xenograft Tumor Development , 2010, Pancreas.

[259]  K. Ohuchida,et al.  CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer. , 2010, Gastroenterology.

[260]  Chenguang Wang,et al.  Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution , 2010, Cell cycle.

[261]  Richard A. Flavell,et al.  The polarization of immune cells in the tumour environment by TGFβ , 2010, Nature Reviews Immunology.

[262]  P. Tonin,et al.  Breast carcinoma-associated fibroblasts rarely contain p53 mutations or chromosomal aberrations. , 2010, Cancer research.

[263]  A. Vincent-Salomon,et al.  Oxidative stress promotes myofibroblast differentiation and tumour spreading , 2010, EMBO molecular medicine.

[264]  A. Klein-Szanto,et al.  Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion , 2010, Proceedings of the National Academy of Sciences.

[265]  E. Cukierman,et al.  Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors. , 2010, Seminars in cancer biology.

[266]  Peter Olson,et al.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.

[267]  J. Campisi,et al.  The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.

[268]  Chunsheng Zhang,et al.  Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers , 2010, Proceedings of the National Academy of Sciences.

[269]  P. Fortina,et al.  The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma , 2009, Cell cycle.

[270]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[271]  Metin N. Gurcan,et al.  Pten in Stromal Fibroblasts Suppresses Mammary Epithelial Tumors , 2009, Nature.

[272]  David Allard,et al.  Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.

[273]  Calvin J Kuo,et al.  Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche , 2009, Nature Medicine.

[274]  O. Halevy,et al.  Inhibition of Transforming Growth Factor &bgr; Signaling by Halofuginone as a Modality for Pancreas Fibrosis Prevention , 2009, Pancreas.

[275]  D. Peeper,et al.  Senescence-messaging secretome: SMS-ing cellular stress , 2009, Nature Reviews Cancer.

[276]  A. Tőkés,et al.  Stromal Matrix Protein Expression Following Preoperative Systemic Therapy in Breast Cancer , 2009, Clinical Cancer Research.

[277]  D. Peeper,et al.  Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network , 2008, Cell.

[278]  J. Mesirov,et al.  Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. , 2008, Cancer research.

[279]  Kylie L. Gorringe,et al.  No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas , 2008, Nature Genetics.

[280]  D. Hanahan,et al.  Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting , 2008, PLoS medicine.

[281]  P. Platzer,et al.  Breast-cancer stromal cells with TP53 mutations and nodal metastases. , 2007, The New England journal of medicine.

[282]  E. Sahai,et al.  Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells , 2007, Nature Cell Biology.

[283]  Liang Xie,et al.  Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. , 2007, Cancer research.

[284]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[285]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[286]  M. Barbacid,et al.  Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. , 2007, Cancer cell.

[287]  Mark W. Kieran,et al.  Identification of fibroblast heterogeneity in the tumor microenvironment , 2006, Cancer biology & therapy.

[288]  E. Cukierman,et al.  Preparation of Extracellular Matrices Produced by Cultured and Primary Fibroblasts , 2006, Current protocols in cell biology.

[289]  A. Larue,et al.  Hematopoietic origin of fibroblasts/myofibroblasts: Its pathophysiologic implications. , 2006, Blood.

[290]  A. Mannermaa,et al.  Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas , 2006, International journal of cancer.

[291]  James Varani,et al.  Decreased collagen production in chronologically aged skin: roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. , 2006, The American journal of pathology.

[292]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[293]  Jun Yao,et al.  Distinct epigenetic changes in the stromal cells of breast cancers , 2005, Nature Genetics.

[294]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[295]  K. Hahm,et al.  Novel Antioxidant Ameliorates the Fibrosis and Inflammation of Cerulein-Induced Chronic Pancreatitis in a Mouse Model , 2005, Pancreatology.

[296]  Rameen Beroukhim,et al.  Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.

[297]  M. Washington,et al.  TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.

[298]  T. Hunt,et al.  Multiple Organ Engraftment by Bone‐Marrow‐Derived Myofibroblasts and Fibroblasts in Bone‐Marrow‐Transplanted Mice , 2003, Stem cells.

[299]  Brian Seed,et al.  Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation , 2003, Nature Medicine.

[300]  José La Rose,et al.  A Positive Regulatory Role for Suppressor of Cytokine Signaling 1 in IFN-γ-Induced MHC Class II Expression in Fibroblasts1 , 2002, The Journal of Immunology.

[301]  C. Denton,et al.  Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis. , 2002, The American journal of pathology.

[302]  J. Campisi,et al.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[303]  W. Reith,et al.  Selective Abrogation of Major Histocompatibility Complex Class II Expression on Extrahematopoietic Cells in Mice Lacking Promoter IV of the Class II Transactivator Gene , 2001, The Journal of experimental medicine.

[304]  A. Nagler,et al.  Halofuginone to prevent and treat thioacetamide‐induced liver fibrosis in rats , 2001, Hepatology.

[305]  G. Bratthauer,et al.  Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. , 2000, Cancer research.

[306]  M. Korsten,et al.  Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis , 1999, Gut.

[307]  R. Schmid,et al.  Identification, culture, and characterization of pancreatic stellate cells in rats and humans. , 1998, Gastroenterology.

[308]  J. Wolfe,et al.  Mammographic features and breast cancer risk: effects with time, age, and menopause status. , 1995, Journal of the National Cancer Institute.

[309]  A. Boots,et al.  Antigen-presenting capacity of rheumatoid synovial fibroblasts. , 1994, Immunology.

[310]  O. Petersen,et al.  Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[311]  Jean Paul Thiery,et al.  Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[312]  B. Haynes,et al.  A novel activation pathway for mature thymocytes. Costimulation of CD2 (T,p50) and CD28 (T,p44) induces autocrine interleukin 2/interleukin 2 receptor-mediated cell proliferation , 1988, The Journal of experimental medicine.

[313]  C. O'neill,et al.  Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts. , 1966, Journal of cell science.

[314]  A. Saluja,et al.  Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression. , 2018, Cancer research.

[315]  S. Phan,et al.  The Bleomycin Model of Pulmonary Fibrosis. , 2017, Methods in molecular biology.

[316]  S. Makpol,et al.  γ-Tocotrienol prevents oxidative stress-induced telomere shortening in human fibroblasts derived from different aged individuals , 2010, Oxidative medicine and cellular longevity.

[317]  C. Betsholtz,et al.  Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts. , 2009, Cancer research.

[318]  R. Coleman,et al.  Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[319]  G. Adler,et al.  Hormone-induced pancreatitis. , 1992, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[320]  R. Behnke,et al.  CHANGES WITH ADVANCING AGE IN THE CELL POPULATION OF HUMAN DERMIS. , 1964, Gerontologia.